Skip to main content
SpringerLink
Log in

Management of Extended Criteria Donors

  • Chapter
  • First Online:
Marginal Donors

  • 630 Accesses

Abstract

Only about 20 % of brain-dead donors in Japan have been fitted in a so-called standard criteria donor for all organs including the heart, lung, liver, pancreas, and kidney. Therefore, it is very important for us to maximize the number of transplantable organs in order to resolve severe donor shortage in Japan [1]. From these aspects, the purposes of donor management are not only to stabilize donor’s hemodynamics until organ procurement surgery but also to maximize donor organ availability and to improve function of extended criteria donor organs. If organ availability is increased, more patients can be saved by organ transplantation. Maximizing donor organ availability is also the last wish of donors and donor families. However, if a transplant recipient died due to a very marginal donor organ, the donor family feels the loss of their loved one again. Therefore, the prevention of primary graft dysfunction (PGD) is essential for the donor family as well as for recipients.

Full - scale donor management begins after the patient is pronounced brain dead and his or her family agrees to donate the organ(s), especially in Japan. In general, donor management is based on the treatment of cardiac and respiratory dysfunction resulting in the improvement of hemodynamics, oxygen supply, and finally other organ function. The targets of hemodynamic parameters are systemic blood pressure >90 mmHg, central venous pressure (CVP) of 6–10 mmHg, urine output of 100 mL/h (0.5–3 mL/kg/h), and heart rate of 80–120 beats/min. As organ procurement surgery begins within 12 h after full-scale donor management is started, it is very different from the usual intensive care to stabilize hemodynamics and to maintain and improve organ function as much as possible in a short period. Moreover, it is important for the physicians who perform donor management to recognize the pathophysiology of brain death from the beginning to completion period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fukushima N, Ono M, Nakatani T, et al. Strategies for maximizing heart and lung transplantation opportunities in Japan. Transplant Proc. 2009;41(1):273–6.

    Article  CAS  PubMed  Google Scholar 

  2. Novitzky D, Cooper DK, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 2006;82(11):1396–401.

    Article  CAS  PubMed  Google Scholar 

  3. Mascia L, Mastromauro I, Viverti S, et al. Management of optimize organ procurement in brain dead donors. Minerva Anestesiol. 2009;75:125–33.

    CAS  PubMed  Google Scholar 

  4. Wood KE, Becker BN, McCartney JG, et al. Current concepts: care of potential organ donor. N Engl J Med. 2004;351:2730–9.

    Article  CAS  PubMed  Google Scholar 

  5. Wilhalem MJ, Pratschke J, Laskowski IA, et al. Brain death and its impact on the donor heart-lessons from animal models. J Heart Lung Transplant. 2000;19:414–8.

    Article  Google Scholar 

  6. Audibert G, Charpentier C, Sequim-Devaux C, et al. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation. 2006;82:1031–6.

    Article  CAS  PubMed  Google Scholar 

  7. Ryan JB, Hicks M, Cropper JR, et al. Functional evidence of reversible ischemic injury immediately after the sympathetic storm associated with experimental brain death. J Heart Lung Trasnplant. 2003;22:922–8.

    Article  Google Scholar 

  8. Rosendale JD, Kauffman HM, McBride MA, et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation. 2003;5(8):1336–41.

    Article  Google Scholar 

  9. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 1998;17:423–9.

    CAS  PubMed  Google Scholar 

  10. Pennefether SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation. 1995;59:58.

    Article  Google Scholar 

  11. Kinoshita Y, Okamoto K, Yahata K, et al. Clinical and pathological changes of the heart in brain death maintained with vasopressin and epinephrine. Pathol Res Pract. 1990;186(1):173–9.

    Article  CAS  PubMed  Google Scholar 

  12. Iwai A, Sakano T, Uenishi M, et al. Effects of vasopressin and catecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation. 1989;48(4):613–7.

    CAS  PubMed  Google Scholar 

  13. Novitzky D, Wicomb WN, Cooper DKC, et al. Electrocardiographic, haemodynamic and endocrine changes occurring during experimental brain death in the chacma baboon. J Heart Transplant. 1984;4:63.

    Google Scholar 

  14. Wicomb WN, Cooper DKC, Lanza RP, et al. The effects of brain death and 24 hours storage by hypothermic perfusion on donor heart function in the pig. J Thorac Cardiovasc Surg. 1986;91:896.

    CAS  PubMed  Google Scholar 

  15. Novitzky D, Wicomb WN, Cooper DKC, Tjaalgard MA. Improved cardiac function following hormonal therapy in brain dead pigs: relevance to organ donation. Cryobiology. 1987;24:1.

    Article  CAS  PubMed  Google Scholar 

  16. Kutsogiannis DJ, Pagliarello G, Doig C, Ross H, Shemie SD. Medical management to optimize donor organ potential: review of the literature. Can J Anaesth. 2006;53(8):820–30.

    Article  PubMed  Google Scholar 

  17. Powner DJ, Hendrich A, Lagler RG, et al. Hormonal changes in brain dead patients. Crit Care Med. 1990;18:785.

    Google Scholar 

  18. Gramm HJ, Meinhold H, Bickel U, et al. Acute endocrine failure after brain death? Transplantation. 1992;54:851.

    Article  CAS  PubMed  Google Scholar 

  19. Randell TT, Hockerstedt KAV. Triiodothyronine treatment in brain-dead multiorgan donors. Transplantation. 1992;54:736.

    Article  CAS  PubMed  Google Scholar 

  20. Goarin JP, Cohen S, Riou B, et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg. 1996;83:41.

    CAS  PubMed  Google Scholar 

  21. Wheeldon DR, Potter CDO, Oduro A, et al. Transforming the “unacceptable” donor: outcomes from adoption of a standardized donor management technique. J Heart Lung Transplant. 1995;14:734.

    CAS  PubMed  Google Scholar 

  22. Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid. 1997;7:139.

    Article  CAS  PubMed  Google Scholar 

  23. Salim A, Vassiliu P, Velmahos GC, et al. The role of thyroid hormone administration in potential organ donors. Arch Surg. 2001;136:1377–80.

    Article  CAS  PubMed  Google Scholar 

  24. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations. Circulation. 2002;106:836.

    Article  PubMed  Google Scholar 

  25. Zaroff JG, Rosengard BR, Armstrong WF, et al. Maximizing use of organs recovered from the cadaver donor: cardiac recommendations. J Heart Lung Transplant. 2002;21:1153.

    Article  Google Scholar 

  26. Keller F, Hemmen T, Schoneshofer M, et al. Pharmacokinetics of methylprednisolone and rejection episodes in kidney transplant patients. Transplantation. 1995;60:330.

    Article  CAS  PubMed  Google Scholar 

  27. Conci F, Di Rienzo M, Castiglioni P. Blood pressure and heart rate variability and baroreflex sensitivity before and after brain death. J Neurol Neurosurg Psychiatry. 2001;71:621–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Rapenne T, Moreau D, Lenfant F, Boggio V, Cottin Y, Freysz M, et al. Could heart rate variability analysis become an early predictor of imminent brain death? A pilot study. Anesth Analg. 2000;91:329–36.

    CAS  PubMed  Google Scholar 

  29. Fukushima N, Shirakura R, Nakata S, et al. Failure of rapid autonomic augmentation of cardiac performance in transplanted hearts. Transplant Proc. 1998;30(7):3344–6. No abstract available.

    Article  CAS  PubMed  Google Scholar 

  30. D'Amico TA, Buchanan SA, Lucke JC, et al. The preservation of cardiac function after brain death: a myocardial pressure-dimension analysis. Surg Forum. 1990;41:277–9.

    Google Scholar 

  31. Sakagoshi N, Shirakura R, Nakano S, et al. Serial changes in myocardial beta-adrenergic receptor after experimental brain death in dogs. J Heart Lung Transplant. 1992;11:1054–8.

    CAS  PubMed  Google Scholar 

  32. Fukushima N, Sakagoshi N, Ohtake S, et al. Effects of exogenous adrenaline on the number of the beta-adrenergic receptors after brain death in humans. Transplant Proc. 2002;34:2571–4.

    Article  CAS  PubMed  Google Scholar 

  33. Milano A, Livi U, Casula R, et al. Influence of marginal donors on early results after heart transplantation. Transplant Proc. 1993;25:3158.

    CAS  PubMed  Google Scholar 

  34. Stoica SC, Satchithananda DK, Charman S, et al. Swan-Ganz catheter assessment of donor hearts: outcome of organs with borderline hemodynamics. J Heart Lung Transplant. 2002;21:615.

    Article  PubMed  Google Scholar 

  35. Ranger GS. Antidiuretic hormone replacement therapy to prevent or ameliorate vasodilatory shock. Med Hypotheses. 2002;59(3):337–40.

    Article  CAS  Google Scholar 

  36. Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain-dead donors and renal function in kidney patients. Lancet. 1998;352:1178.

    Article  CAS  PubMed  Google Scholar 

  37. Marques RG, Rogers J, Chavin KD, et al. Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc. 2004;36:1048.

    Article  CAS  PubMed  Google Scholar 

  38. Hoefer D, Ruttmann-Ulmer E, Smits JM, Devries E, Antretter H, Laufer G. Donor hypo- and hypernatremia are predictors for increased 1-year mortality after cardiac transplantation. Transpl Int. 2010;23(6):589–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Therapeutics for End-Stage Organ Dysfunction, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan

    Norihide Fukushima

Authors
  1. Norihide Fukushima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norihide Fukushima .

Editor information

Editors and Affiliations

  1. Department of Surgery and Clinical Research Center, Chiba-East National Hospital,, Chiba, Japan

    Takehide Asano

  2. Department of Therapeutics for End-Stage Organ Dysfunction, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

    Norihide Fukushima

  3. Department of Organ Transplant Surgery, Fujita Health University, Aichi, Japan

    Takashi Kenmochi

  4. Division for Innovative Surgery and Transplantation, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan

    Naoto Matsuno

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Japan

About this chapter

Cite this chapter

Fukushima, N. (2014). Management of Extended Criteria Donors. In: Asano, T., Fukushima, N., Kenmochi, T., Matsuno, N. (eds) Marginal Donors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54484-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54484-5_2

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54483-8

  • Online ISBN: 978-4-431-54484-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation